Trials / Completed
CompletedNCT00711386
GSK706769 Repeat Dose Study
A Double-Blind, Randomized, Placebo-Controlled, Repeat Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK706769 in Healthy Male and Female Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To determine safety, tolerability and Pharmacokinetics of GSK706769
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GSK706769 | 50mg, 100mg, 200mg, or 400mg |
| OTHER | Placebo | Placebo |
Timeline
- Start date
- 2008-05-16
- Primary completion
- 2008-09-12
- Completion
- 2008-09-12
- First posted
- 2008-07-08
- Last updated
- 2017-08-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00711386. Inclusion in this directory is not an endorsement.